Health Care

U.S. stocks are edging higher Thursday morning as technology companies and banks advance.

Amazon executives remained mum Thursday on rumors that the e-commerce giant is taking steps to become a wholesale distributor of pharmaceuticals.

Amazon.com has struck again. Only this time the internet giant is shaking up an industry it hasn't yet entered.

A blockbuster pharma-health insurance deal is said to be in the works.

The latest on developments in financial markets (All times local): Stocks are opening higher on Wall Street led by technology companies and banks as the market regains most of the previous day's losses.

PHOENIX (AP) — U.S. prosecutors brought a fraud and racketeering case Thursday against the founder of an opioid medication maker, Insys Therapeutics (NASDAQ:INSY), that has faced increasing scrutiny from authorities across the country over allegations of pushing prescriptions of powerful painkillers amid a drug epidemic that is claiming thousands of lives each year.

General Electric Co is exploring divesting its transportation and health care information technology businesses, as it seeks to reshape its portfolio under new Chief Executive John Flannery, people familiar with the matter said.

As the White House gets ready to declare the opioid epidemic a public health emergency on Thursday, pharmacies are taking matters into their own hands, stocking an FDA-approved drug that can reverse the effects of an opioid overdose.

Shares of Celgene are plunging after the drugmaker missed revenue forecasts and dialed back is outlook.

Fisher-Price is voluntarily recalling about 65,000 motorized infant seats because of risk of a fire hazard.

Bristol-Myers Squibb Co. (BMY) on Thursday reported third-quarter earnings of $845 million.

Pfizer plans to kick off an auction process for its consumer healthcare business in November, paving the way for a potential $15 billion-plus sale of the headache pill to lip balm business, sources close to the matter told Reuters.

A U.S. judge in California refused to block President Donald Trump's decision to end subsidy payments to health insurers under Obamacare.

The U.S. Food and Drug Administration has rejected an experimental drug for a common type of muscular dystrophy.

Ford is recalling over 73,000 full-sized vans in North America to fix a wiring problem that could cause fires and other electrical issues.

House Speaker Paul Ryan said on Wednesday the Republican-controlled U.S. Congress will not attempt to repeal and replace Obamacare again this year but should try again in 2018.

Drugmaker GlaxoSmithKline says third-quarter sales rose 4 percent, driven by new products such as the company's Tivicay HIV treatment and Ellipta respiratory therapy.